as on November 28, 2025 at 11:29 pm IST
Day's Low
Day's High
1.53%
Downside
0.24%
Upside
52 Week's Low
52 Week's High
62.50%
Downside
0.48%
Upside
Check Revolution Medicines Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$15.0B
EPS (TTM)
-5.5362
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-13.45
Industry PE ratio
8.214070796460177
PEG Ratio
0EBITDA
-1.0B
Revenue (TTM)
742.0K
Profit Margin
0.00%
Return On Equity TTM
-60.76%
Track how Revolution Medicines Inc P/E has moved over time to understand its valuation trends.
Revolution Medicines Inc in the last 5 years
Lowest (-23.23x)
March 31, 2021
Today (-13.45x)
November 29, 2025
Industry (8.21x)
November 29, 2025
Highest (-6.37x)
December 31, 2023
Today’s Price to Earnings Ratio: -13.45x
Compare market cap, revenue, PE, and other key metrics of Revolution Medicines Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $15.0B | 76.85% | -13.45 | 0.00% | |
| BUY | $44.3B | 422.04% | -16.34 | -264.83% | |
| BUY | $58.8B | 247.47% | 1435.87 | 1.36% | |
| BUY | $110.8B | 91.26% | 30.39 | 31.35% | |
| BUY | $83.2B | 51.77% | 18.8 | 32.13% |
The Revolution Medicines Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Revolution Medicines Inc investment value today
Current value as on today
₹1,40,107
Returns
₹40,107
(+40.11%)
Returns from Revolution Medicines Inc Stock
₹34,468 (+34.47%)
Dollar Returns*
₹5,638 (+5.64%)
Based on 19 analysts
94.74%
Buy
5.26%
Hold
0.00%
Sell
Based on 19 analysts, 94.74% of analysts recommend a 'BUY' rating for Revolution Medicines Inc. Average target price of $81.15
Get share price movements and forecasts by analysts on Revolution Medicines Inc.
What analysts predicted
4.14%UPSIDE
Target Price
$81.15
Current Price
$77.79
Analyzed by
19 Analysts
Target
$81.15
Revolution Medicines Inc target price $81.15, a slight upside of 4.14% compared to current price of $77.79. According to 19 analysts rating.
Search interest for Revolution Medicines Inc Stock has increased by 207% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:207% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 27 October
Mon, 05:48 PM
-Revolution Medicines receives FDA Orphan Drug Designation for daraxonrasib, targeting pancreatic cancer treatment.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 742.0K → 261.59M (in $), with an average increase of 99.7% per quarter
Price Rise
![]()
In the last 1 month, RVMD stock has moved up by 32.1%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 1023.7% return, outperforming this stock by 794.1%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 176.4% return, outperforming this stock by 142.0%
Profit Down
![]()
Netprofit is down for the last 7 quarters, -116.00M → -305.20M (in $), with an average decrease of 17.6% per quarter
| Organisation | Revolution Medicines Inc |
| Headquarters | 700 Saginaw Drive, Redwood City, CA, United States, 94063 |
| Industry | Health Technology |
| CEO | Dr. Mark A. Goldsmith M.D., Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Xiaolin Wang | Executive Vice President of Development |
Mr. Walter Reiher Ph.D. | Chief Information Officer |
Ms. Jan Smith Ph.D. | Chief Scientific Officer |
Mr. Jack Anders | Chief Financial Officer |
Dr. Stephen M. Kelsey FRC Path., FRCP, M.D. | President of Research & Development |
Dr. Martin D. Burke M.D., Ph.D. | Co-Founder & Chairman of Scientific Advisory Board |
Dr. Michael A. Fischbach Ph.D. | Academic Co-Founder & Member of Scientific Advisory Board |
Dr. Kevan M. Shokat Ph.D. | Academic Co-Founder & Member of Scientific Advisory Board |
Dr. Mark A. Goldsmith M.D., Ph.D. | CEO, President & Chairman |
Ms. Margaret A. Horn J.D. | Chief Operating Officer |
Revolution Medicines Inc share price today is $77.79 as on at the close of the market. Revolution Medicines Inc share today touched a day high of $77.98 and a low of $76.6.
Revolution Medicines Inc share touched a 52 week high of $78.17 on and a 52 week low of $29.17 on . Revolution Medicines Inc stock price today i.e. is closed at $77.79,which is 0.48% down from its 52 week high and 166.68% up from its 52 week low.
Revolution Medicines Inc market capitalisation is $0.01T as on .
Indian investors can start investing in Revolution Medicines Inc (RVMD) shares with as little as ₹89.332 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹893.32 in Revolution Medicines Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Revolution Medicines Inc share’s latest price of $77.79 as on November 28, 2025 at 11:29 pm IST, you will get 0.1286 shares of Revolution Medicines Inc. Learn more about
fractional shares .
Revolution Medicines Inc stock has given 76.85% share price returns and 20.49% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?